References
- Kuskin S M, Wang S C, Rugh R. Protective effect of artificially induced hibernation against lethal doses of whole body x-irradiation in CF1 male mice. Am J Physiol 1959; 196: 1211–3
- Reinhardt K. Zur Problematik vom Bestrahlungsversuchen in Hypothermie und Winterschlaf. Strahlentherapie 1967; 133: 396–405
- Sisken J E, Morasca L, Kibby S. Effects of temperature on the kinetics of the mitotic cycle of mammalian cells in culture. Exp Cell Res 1965; 39: 103–16
- Balmukhanov S B, Karakulov R K. Cellular mechamisms of the radiomodifying effect of hypothermia. Neoplasma 1978; 25: 585–93
- Condon H A. Protective hypothermia for cancer chemotherapy. Br J Anaesth 1967; 39: 806–12
- Popovic P, Schaffer R, Popovic V. Beneficial effects of hypothermia in BCNU therapy. Proc Am Ass Cancer Res 1977; 18: 71
- Gailis L. Chlorpromazine hypothermia protects mice against doxorubicin toxicity. Fed Proc 1982; 41: 1715
- Oleson J R, Dewhirst M W. Hyperthermia: an overview of current progress and problems. Curr Probl Cancer 1983; 8: 1–62
- Warburg O. The metabolism of tumours. Constable, London 1930
- Aisenberg A C. The glycolysis and respiration of tumours. Acad Press, New York, London 1961
- Popovic P, Popovic V, Weathers D. Effect of differential hypothermia and 5-Fluoro-uracil on C3H mouse mammary tumours (Histologic study). Cryobiology 1976; 13: 347–53
- Gailis L, Dumas L, Page M. Ambiguous effect of chlorpromazine on doxorubicin activity against P388D1 tumors in mice. Ann Meet Proc Am Ass Cancer Res 1986; 27: 238
- Swan H. Clinical hypothermia: A lady with a past and some promise for the future. Surgery 1973; 73: 736–58
- Hagmar B. MCG101-AA, a new ascites tumour in C57 mice. 1. Induction procedures and some cytological and physio-chemical characteristics. Acta Pathol Microbiol Scand (Sect A) 1974; 82: 358–68
- Hagmar B. MCG101-AA, a new ascites tumour in C57 mice. 2. Protocol of in vivo transplantation studies in comparison with the solid (SS) and solid ascites (AS) tumours. Acta Pathol Microbiol Scand (Sect A) 1974; 82: 369–78
- Bodansky O. Biochemistry of human cancer. Acad Press, New York, London 1975
- Edelstyn G A, MacDonald M, MacRae K D. Doxorubicin-induced hair loss and possible modification by scalp cooling. Lancet 1977; 2: 253–4
- Hemminki K, Ludlum D B. Covalent modification of DNA by antineoplastic agents. J Natl Cancer Inst 1984; 73: 1021–8
- Beuder R A, Chabner B A. Tubulin binding agents. Pharmacologic principles of cancer treatment, B A Chabner. WB Saunders Co, Philadelphia 1982; 256–68
- Dustin P. Microtubules. Springer-Verlag, Berlin 1984
- Darkin S, McQuillan J, Ralph R K. Chlorpromazine: a potential anticancer agent?. Biochem Biophys Res Commun 1984; 125: 184–91
- Gailis L, Gagnon F, Dagenais G R. Chlorpromazine protection against doxorubicin toxicity: dependence on hypothermia. Fed Proc 1986; 45: 573